$683 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 119 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 49.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | SPDR S&P 500 ETF TRput | $81,548,000 | +73.6% | 400,000 | +16219.9% | 11.94% | +99.2% | |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $51,517,000 | +21.2% | 784,850 | +4.2% | 7.54% | +39.1% |
| ORA | Buy | ORMAT TECHNOLOGIES INC | $38,744,000 | +120.8% | 272,462 | +105.4% | 5.67% | +153.4% |
| PFE | Buy | PFIZER INC | $37,981,000 | +110.7% | 1,176,612 | +105.0% | 5.56% | +141.8% |
| BIIB | Buy | BIOGEN INC | $37,941,000 | +53.0% | 123,850 | +45.7% | 5.56% | +75.5% |
| AGN | Sell | ALLERGAN PLC | $31,250,000 | -35.1% | 100,000 | -43.5% | 4.58% | -25.5% |
| Buy | SPDR SERIES TRUSTput | $23,152,000 | -38.0% | 329,800 | +5396.7% | 3.39% | -28.9% | |
| ABBV | Buy | ABBVIE INC | $21,445,000 | +20.5% | 362,000 | +10.7% | 3.14% | +38.3% |
| CELG | Buy | CELGENE CORP | $17,629,000 | +35.8% | 147,200 | +22.7% | 2.58% | +55.9% |
| Buy | MYLAN N Vcall | $16,221,000 | +34.3% | 300,000 | +9900.0% | 2.38% | +54.1% | |
| GILD | Buy | GILEAD SCIENCES INC | $14,440,000 | +22.5% | 142,700 | +18.9% | 2.11% | +40.7% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $11,286,000 | +106.2% | 59,164 | +69.0% | 1.65% | +136.7% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $8,358,000 | -5.9% | 121,500 | -19.0% | 1.22% | +8.0% |
| SHPG | Sell | SHIRE PLCsponsored adr | $8,200,000 | -38.1% | 40,000 | -76.4% | 1.20% | -29.0% |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $6,118,000 | -14.5% | 143,000 | -47.0% | 0.90% | -1.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $6,090,000 | +46.2% | 48,400 | +21.0% | 0.89% | +67.7% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $6,018,000 | +123.5% | 145,000 | -17.1% | 0.88% | +156.1% |
| GOOGL | New | GOOGLE INCcl a | $5,764,000 | – | 7,409 | +100.0% | 0.84% | – |
| INCY | Sell | INCYTE CORP | $5,598,000 | -49.3% | 51,621 | -48.4% | 0.82% | -41.8% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $5,422,000 | +1499.4% | 93,000 | +1062.5% | 0.79% | +1746.5% |
| CELJF | Sell | CELLCOM ISRAEL LTD | $5,144,000 | -41.5% | 212,300 | -40.6% | 0.75% | -32.9% |
| OPK | New | OPKO HEALTH INC | $5,025,000 | – | 500,000 | +100.0% | 0.74% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $5,029,000 | – | 81,200 | +100.0% | 0.74% | – |
| MGNX | Sell | MACROGENICS INC | $4,738,000 | +30.1% | 153,000 | -10.0% | 0.69% | +49.2% |
| BLCM | Buy | BELLICUM PHARMACEUTICALS INC | $4,693,000 | +39.5% | 231,515 | +0.0% | 0.69% | +60.1% |
| CHKP | Sell | CHECK POINT SOFTWARE TECH LTord | $4,546,000 | -20.8% | 55,857 | -22.8% | 0.67% | -9.0% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $4,399,000 | +8.6% | 85,500 | -10.0% | 0.64% | +24.6% |
| MRNS | Buy | MARINUS PHARMACEUTICALS INC | $4,362,000 | +222.6% | 570,908 | +252.2% | 0.64% | +271.5% |
| RDUS | New | RADIUS HEALTH INC | $4,308,000 | – | 70,000 | +100.0% | 0.63% | – |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $4,302,000 | -25.7% | 462,051 | -10.0% | 0.63% | -14.7% |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $4,248,000 | – | 150,000 | +100.0% | 0.62% | – |
| ITEK | Buy | INOTEK PHARMACEUTICALS CORP | $4,079,000 | +47.1% | 360,000 | +22.0% | 0.60% | +68.6% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $3,766,000 | +17.2% | 40,000 | 0.0% | 0.55% | +34.4% | |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS INC | $3,716,000 | -9.3% | 112,500 | -10.0% | 0.54% | +4.2% |
| ORBK | Buy | ORBOTECH LTDord | $3,709,000 | +205.8% | 167,619 | +113.6% | 0.54% | +250.3% |
| KMPH | Sell | KEMPHARM INC | $3,653,000 | -7.8% | 183,954 | -10.0% | 0.54% | +5.9% |
| HRTX | Buy | HERON THERAPEUTICS INC | $3,605,000 | +195.5% | 135,000 | +170.0% | 0.53% | +238.5% |
| New | GOOGLE INCcall | $3,579,000 | – | 4,600 | +100.0% | 0.52% | – | |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $3,565,000 | +8.0% | 1,455,000 | +32.3% | 0.52% | +24.0% |
| RPTP | Buy | RAPTOR PHARMACEUTICAL CORP | $3,562,000 | +0.8% | 685,000 | +17.3% | 0.52% | +15.7% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $3,565,000 | – | 100,000 | +100.0% | 0.52% | – |
| New | GW PHARMACEUTICALS PLCcall | $3,472,000 | – | 50,000 | +100.0% | 0.51% | – | |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $3,431,000 | +22.1% | 33,750 | +114.3% | 0.50% | +40.2% |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $3,415,000 | -9.0% | 180,000 | -10.0% | 0.50% | +4.4% |
| TJX | Buy | TJX COS INC NEW | $3,401,000 | +14.7% | 47,961 | +15.6% | 0.50% | +31.7% |
| ANAC | Buy | ANACOR PHARMACEUTICALS INC | $3,389,000 | +187.9% | 30,000 | +200.0% | 0.50% | +230.7% |
| ADRO | New | ADURO BIOTECH INC | $3,377,000 | – | 120,000 | +100.0% | 0.49% | – |
| NVAX | Buy | NOVAVAX INC | $3,356,000 | +216.3% | 400,000 | +166.7% | 0.49% | +263.7% |
| CARA | Sell | CARA THERAPEUTICS INC | $3,335,000 | +6.2% | 197,820 | -10.0% | 0.49% | +21.7% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $3,308,000 | -65.7% | 94,500 | -10.0% | 0.48% | -60.7% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,246,000 | – | 50,000 | +100.0% | 0.48% | – |
| EGLTQ | Sell | EGALET CORP | $3,223,000 | -24.8% | 292,500 | -10.0% | 0.47% | -13.7% |
| SGEN | Buy | SEATTLE GENETICS INC | $3,142,000 | +63.0% | 70,000 | +40.0% | 0.46% | +87.0% |
| KITE | Sell | KITE PHARMA INC | $3,081,000 | -2.9% | 50,000 | -12.2% | 0.45% | +11.4% |
| MDLZ | Buy | MONDELEZ INTL INCcl a | $3,077,000 | +23.6% | 68,625 | +15.4% | 0.45% | +41.8% |
| IMDZ | Sell | IMMUNE DESIGN CORP | $3,072,000 | +48.1% | 153,000 | -10.0% | 0.45% | +69.8% |
| ARWR | Sell | ARROWHEAD RESH CORP | $2,989,000 | -3.9% | 486,000 | -10.0% | 0.44% | +10.3% |
| MA | New | MASTERCARD INCcl a | $2,980,000 | – | 30,605 | +100.0% | 0.44% | – |
| XLRN | Sell | ACCELERON PHARMA INC | $2,926,000 | +17.5% | 60,000 | -40.0% | 0.43% | +34.6% |
| GNCA | Buy | GENOCEA BIOSCIENCES INC | $2,848,000 | +10.2% | 540,490 | +43.3% | 0.42% | +26.4% |
| V | New | VISA INC | $2,838,000 | – | 36,600 | +100.0% | 0.42% | – |
| SBUX | Sell | STARBUCKS CORP | $2,811,000 | -21.1% | 46,828 | -25.3% | 0.41% | -9.5% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $2,774,000 | -0.4% | 342,000 | -10.0% | 0.41% | +14.4% |
| BITI | Sell | BIOTIE THERAPIES OYJsponsored adr | $2,740,000 | +6.4% | 193,646 | -1.6% | 0.40% | +21.9% |
| PTNR | PARTNER COMMUNICATIONS CO LTadr | $2,700,000 | +11.8% | 617,951 | 0.0% | 0.40% | +28.2% | |
| HON | New | HONEYWELL INTL INC | $2,651,000 | – | 25,595 | +100.0% | 0.39% | – |
| RTRX | Sell | RETROPHIN INC | $2,604,000 | -14.3% | 135,000 | -10.0% | 0.38% | -1.8% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $2,603,000 | -38.3% | 48,400 | -54.1% | 0.38% | -29.2% |
| EXEL | Sell | EXELIXIS INC | $2,538,000 | -9.5% | 450,000 | -10.0% | 0.37% | +3.9% |
| QURE | Buy | UNIQURE NV | $2,539,000 | +8.0% | 153,500 | +33.5% | 0.37% | +24.0% |
| CLCD | Sell | COLUCID PHARMACEUTICALS INC | $2,390,000 | +94.6% | 285,525 | -10.0% | 0.35% | +122.9% |
| AAP | New | ADVANCE AUTO PARTS INC | $2,341,000 | – | 15,555 | +100.0% | 0.34% | – |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $2,340,000 | +16.1% | 135,000 | -10.0% | 0.34% | +33.5% |
| SMMT | Sell | SUMMIT THERAPEUTICS PLCspons ads | $2,321,000 | +8.7% | 202,220 | -1.5% | 0.34% | +24.5% |
| FWP | Sell | FORWARD PHARMA A/Ssponsored adr | $2,309,000 | -27.4% | 121,500 | -10.0% | 0.34% | -16.7% |
| DMTX | New | DIMENSION THERAPEUTICS INC | $2,256,000 | – | 200,000 | +100.0% | 0.33% | – |
| MDCO | New | MEDICINES CO | $2,240,000 | – | 60,000 | +100.0% | 0.33% | – |
| CTSH | New | COGNIZANT TECHNOLOGY SOLUTIOcl a | $2,197,000 | – | 36,600 | +100.0% | 0.32% | – |
| VTAE | New | VITAE PHARMACEUTICALS INC | $2,172,000 | – | 120,000 | +100.0% | 0.32% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $2,174,000 | -11.4% | 90,000 | -10.0% | 0.32% | +1.6% |
| PTCT | Buy | PTC THERAPEUTICS INC | $2,139,000 | +1899.1% | 66,020 | +1550.5% | 0.31% | +2135.7% |
| PTN | Sell | PALATIN TECHNOLOGIES INC | $2,080,000 | -23.5% | 3,132,926 | -6.7% | 0.30% | -12.1% |
| CYNA | Sell | CYNAPSUS THERAPEUTICS INC | $2,070,000 | -32.3% | 134,037 | -29.1% | 0.30% | -22.3% |
| ABUS | Sell | ARBUTUS BIOPHARMA CORP | $2,023,000 | -34.2% | 454,500 | -10.0% | 0.30% | -24.5% |
| ABEO | ABEONA THERAPEUTICS INC | $2,016,000 | -17.0% | 600,000 | 0.0% | 0.30% | -4.8% | |
| AXSM | New | AXSOME THERAPEUTICS INC | $2,009,000 | – | 220,000 | +100.0% | 0.29% | – |
| EDGE | New | EDGE THERAPEUTICS INC | $1,938,000 | – | 155,000 | +100.0% | 0.28% | – |
| SCYX | Sell | SCYNEXIS INC | $1,892,000 | -17.0% | 304,600 | -2.7% | 0.28% | -4.8% |
| TBRA | Buy | TOBIRA THERAPEUTICS INC | $1,886,000 | +41.9% | 187,622 | +36.3% | 0.28% | +62.4% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $1,855,000 | +12.6% | 810,000 | -10.0% | 0.27% | +29.5% |
| NVLS | Buy | NIVALIS THERAPEUTICS INC | $1,792,000 | -31.5% | 231,548 | +14.8% | 0.26% | -21.6% |
| OCRX | Buy | OCERA THERAPEUTICS INC | $1,716,000 | +8.6% | 550,000 | +10.0% | 0.25% | +24.3% |
| Sell | TRILLIUM THERAPEUTICS INC | $1,668,000 | -12.9% | 132,300 | -10.0% | 0.24% | 0.0% | |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $1,652,000 | -58.0% | 23,790 | -44.8% | 0.24% | -51.8% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $1,617,000 | +4.7% | 238,500 | -10.0% | 0.24% | +20.3% |
| TSRO | Sell | TESARO INC | $1,605,000 | -65.9% | 30,686 | -73.9% | 0.24% | -60.9% |
| NVS | Sell | NOVARTIS A Gsponsored adr | $1,549,000 | -15.7% | 18,000 | -10.0% | 0.23% | -3.4% |
| NBRV | Sell | NABRIVA THERAPEUTICS AGsponsored adr | $1,504,000 | -9.6% | 157,500 | -10.0% | 0.22% | +3.8% |
| AXTA | Buy | AXALTA COATING SYS LTD | $1,497,000 | +45.5% | 56,173 | +38.3% | 0.22% | +67.2% |
| NXPI | New | NXP SEMICONDUCTORS N V | $1,426,000 | – | 16,920 | +100.0% | 0.21% | – |
| SBBP | New | STRONGBRIDGE BIOPHARMA PLC | $1,382,000 | – | 181,818 | +100.0% | 0.20% | – |
| PRQR | New | PROQR THRAPEUTICS N V | $1,302,000 | – | 150,000 | +100.0% | 0.19% | – |
| CBYL | Sell | CARBYLAN THERAPEUTICS INC | $1,303,000 | -8.8% | 360,000 | -10.0% | 0.19% | +4.9% |
| LOXO | New | LOXO ONCOLOGY INC | $1,280,000 | – | 45,000 | +100.0% | 0.19% | – |
| New | MANNKIND CORPcall | $1,102,000 | – | 760,000 | +100.0% | 0.16% | – | |
| WAB | Sell | WABTEC CORP | $908,000 | -54.6% | 12,761 | -43.9% | 0.13% | -47.8% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $907,000 | -43.2% | 215,000 | -38.6% | 0.13% | -34.8% |
| 3106PS | Buy | DELPHI AUTOMOTIVE PLC | $863,000 | +24.0% | 10,065 | +10.0% | 0.13% | +41.6% |
| ELLO | Sell | ELLOMAY CAPITAL LIMITED | $824,000 | -64.7% | 95,653 | -56.7% | 0.12% | -59.4% |
| WIX | Sell | WIX COM LTD | $807,000 | -20.3% | 35,460 | -39.0% | 0.12% | -8.5% |
| CHTR | CHARTER COMMUNICATIONS INC Dcl a new | $737,000 | +4.1% | 4,026 | 0.0% | 0.11% | +20.0% | |
| CATB | Sell | CATABASIS PHARMACEUTICALS IN | $640,000 | -75.3% | 80,742 | -75.3% | 0.09% | -71.6% |
| EZCH | New | EZCHIP SEMICONDUCTOR LIMITEDord | $505,000 | – | 20,447 | +100.0% | 0.07% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $388,000 | -97.1% | 3,700 | -97.0% | 0.06% | -96.6% |
| LIFE | Sell | ATYR PHARMA INC | $358,000 | -83.3% | 36,450 | -82.6% | 0.05% | -81.0% |
| GNVC | Sell | GENVEC INC | $343,000 | -58.8% | 186,500 | -48.2% | 0.05% | -52.8% |
| ICL | New | ISRAEL CHEMICALS LTD | $280,000 | – | 69,083 | +100.0% | 0.04% | – |
| AOS | Sell | SMITH A O | $207,000 | -69.6% | 2,700 | -74.1% | 0.03% | -65.5% |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -200 | -100.0% | -0.00% | – |
| NICE | Exit | NICE SYS LTDsponsored adr | $0 | – | -4,525 | -100.0% | -0.03% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -40,000 | -100.0% | -0.16% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -120,000 | -100.0% | -0.21% | – |
| PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -10,002 | -100.0% | -0.22% | – |
| Exit | NEURODERM LTD | $0 | – | -85,000 | -100.0% | -0.22% | – | |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -55,000 | -100.0% | -0.22% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -150,000 | -100.0% | -0.25% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -107,000 | -100.0% | -0.25% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.26% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -45,133 | -100.0% | -0.26% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -75,000 | -100.0% | -0.27% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -700,000 | -100.0% | -0.31% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -372,250 | -100.0% | -0.32% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -0.35% | – |
| ISIS | Exit | ISIS PHARMACEUTICALS INC | $0 | – | -68,000 | -100.0% | -0.35% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -17,500 | -100.0% | -0.37% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.37% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -30,700 | -100.0% | -0.38% | – |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -512,500 | -100.0% | -0.38% | – |
| INSM | Exit | INSMED INC | $0 | – | -165,000 | -100.0% | -0.39% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -85,230 | -100.0% | -0.43% | – |
| Exit | ARRAY BIOPHARMA INCcall | $0 | – | -7,500 | -100.0% | -0.44% | – | |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -28,840 | -100.0% | -0.48% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -200,000 | -100.0% | -0.51% | – |
| Exit | PTC THERAPEUTICS INCcall | $0 | – | -1,600 | -100.0% | -0.54% | – | |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -310,000 | -100.0% | -0.55% | – |
| XLY | Exit | SELECT SECTOR SPDR TRsbi cons discr | $0 | – | -89,216 | -100.0% | -0.84% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -360,000 | -100.0% | -0.87% | – |
| Exit | HORIZON PHARMA PLCcall | $0 | – | -3,500 | -100.0% | -0.88% | – | |
| AMGN | Exit | AMGEN INC | $0 | – | -50,200 | -100.0% | -0.89% | – |
| MYL | Exit | MYLAN N V | $0 | – | -200,000 | -100.0% | -1.03% | – |
| PRGO | Exit | PERRIGO CO PLCcall | $0 | – | -547 | -100.0% | -1.10% | – |
| ESLT | Exit | ELBIT SYS LTDord | $0 | – | -100,618 | -100.0% | -3.72% | – |
| Exit | ISHARES TRput | $0 | – | -1,000 | -100.0% | -3.87% | – | |
| Exit | SELECT SECTOR SPDR TRput | $0 | – | -10,000 | -100.0% | -8.45% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.